Translational Research on Oncology – Trademark Portfolio
Entity Type: 99
Translational Research on Oncology holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include TRIO. The owner is based in Edmonton, Alberta.
Suite 1100
Edmonton, Alberta T5K2J8 , CA
Showing of trademarks Trademarks
Trademark Classifications
Translational Research on Oncology's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Translational Research on Oncology have?
Translational Research on Oncology has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Translational Research on Oncology file in?
Translational Research on Oncology files trademarks across 1 Nice Classification class. The most active classes are Class 42 (Computer & Scientific). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Translational Research on Oncology's most well-known trademarks?
Translational Research on Oncology's registered trademark portfolio includes well-known marks such as TRIO. These are among 1 currently registered trademark in the portfolio.
What is Translational Research on Oncology's trademark registration success rate?
Translational Research on Oncology has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.